2025 United States Anatomic Pathology Market Revenue Opportunities Report
Description
The 2025 United States Anatomic Pathology Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anatomic Pathology Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the U.S. anatomic pathology market are Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, and Roche. Quest Diagnostics is a leader in clinical and anatomic pathology diagnostics, processing over 300,000 tests daily with advanced automation and precision medicine capabilities. LabCorp offers comprehensive pathology services including molecular diagnostics and oncology testing, with global reach and innovation in genomic medicine. Thermo Fisher Scientific, through its specialty diagnostic products and anatomical pathology division (operated as Epredia), provides lab equipment and reagents critical for pathology workflows. Roche is prominent in molecular and immunohistochemistry diagnostics, enhancing cancer and disease diagnoses.
These companies drive the U.S. anatomic pathology market's growth by integrating advanced technologies such as digital pathology, artificial intelligence, and automation to improve diagnostic accuracy and efficiency. Their extensive lab networks and investments support high-volume, rapid-testing environments crucial for hospital and clinical laboratory segments, which dominate the market. Moreover, ongoing innovations in personalized medicine and molecular pathology by these leaders foster improved patient outcomes and underpin market expansion projected to reach nearly USD 21 billion by 2034.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Anatomic Pathology Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the U.S. anatomic pathology market are Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, and Roche. Quest Diagnostics is a leader in clinical and anatomic pathology diagnostics, processing over 300,000 tests daily with advanced automation and precision medicine capabilities. LabCorp offers comprehensive pathology services including molecular diagnostics and oncology testing, with global reach and innovation in genomic medicine. Thermo Fisher Scientific, through its specialty diagnostic products and anatomical pathology division (operated as Epredia), provides lab equipment and reagents critical for pathology workflows. Roche is prominent in molecular and immunohistochemistry diagnostics, enhancing cancer and disease diagnoses.
These companies drive the U.S. anatomic pathology market's growth by integrating advanced technologies such as digital pathology, artificial intelligence, and automation to improve diagnostic accuracy and efficiency. Their extensive lab networks and investments support high-volume, rapid-testing environments crucial for hospital and clinical laboratory segments, which dominate the market. Moreover, ongoing innovations in personalized medicine and molecular pathology by these leaders foster improved patient outcomes and underpin market expansion projected to reach nearly USD 21 billion by 2034.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
